Skip to main content

Table 5 Tumour cell morphology

From: Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study

  Morphology
Excellent 33/214 15.5%
Good 144/214 67.0%
Reasonable 32/214 15.0%
Poor 5/214 2.5%